|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.365
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.258
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.243
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.225
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.222
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.167
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.158
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.111
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.103
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.097
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.095
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.085
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.082
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.081
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.072
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.069
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.067
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.064
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.062
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.061
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.061
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.061
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.059
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.058
|
|
|
|
regulation of tooth mineralization
|
GO:0070170 |
2 |
0.058
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.058
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.055
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.053
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.052
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.051
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.051
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.049
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.049
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.048
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.048
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.048
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.048
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.048
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.048
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.046
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.045
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.045
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.045
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.044
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.044
|
|
|
|
fibril organization
|
GO:0097435 |
2 |
0.043
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.043
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.042
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.041
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.041
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.041
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.040
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.040
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.039
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.039
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.038
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.036
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.036
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.035
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.033
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.032
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.031
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.031
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.031
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.030
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.030
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.030
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.029
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.029
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.029
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.029
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.029
|
|
|
|
extracellular fibril organization
|
GO:0043206 |
2 |
0.029
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.028
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.028
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.028
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.027
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.027
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.027
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.027
|
|
|
|
protein hydroxylation
|
GO:0018126 |
4 |
0.027
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.027
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.027
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.027
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.026
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.026
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.026
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.026
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.026
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.026
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.026
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.026
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.025
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.025
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.025
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.025
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.025
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.025
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.025
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.025
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.025
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.025
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.025
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.025
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.024
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.024
|
|
|
|
bone trabecula morphogenesis
|
GO:0061430 |
12 |
0.024
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.024
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.024
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.024
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.024
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.023
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.023
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.023
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.023
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.023
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.023
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.022
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.022
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.022
|
|
|
|
bone trabecula formation
|
GO:0060346 |
9 |
0.022
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.022
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.022
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.022
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.021
|
|
|
|
positive regulation of vesicle fusion
|
GO:0031340 |
2 |
0.021
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.021
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.021
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.021
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.021
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.021
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.021
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.021
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.021
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.020
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.020
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.020
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.020
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.020
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.020
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.020
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.019
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.019
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.019
|
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
26 |
0.019
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.019
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.019
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.019
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.018
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.018
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.018
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.018
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.018
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.018
|
|
|
|
negative regulation of tooth mineralization
|
GO:0070171 |
1 |
0.018
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.018
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.018
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.018
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.018
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.018
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.018
|
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.018
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.018
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.017
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.017
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.017
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.017
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.017
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.017
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.017
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.017
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.017
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.017
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.017
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.016
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.016
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.016
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.016
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.016
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.016
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.016
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.016
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.016
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.016
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.016
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.016
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.016
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.016
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.015
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.015
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.015
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.015
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.015
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.015
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.015
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.015
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.015
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.015
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.015
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.015
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.015
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.015
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.015
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.015
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.015
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.015
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.014
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.014
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.014
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.014
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.014
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
16 |
0.014
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.014
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.014
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.014
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.014
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.014
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.014
|
|
|
|
cellular response to x ray
|
GO:0071481 |
2 |
0.014
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.014
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.014
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.014
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.014
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.013
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.013
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.013
|
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
16 |
0.013
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.013
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.013
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.013
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.013
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.013
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.013
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.013
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.013
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.013
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.013
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.013
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.013
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.013
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.013
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.013
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.013
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.013
|
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.013
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.013
|
|
|
|
negative regulation of cell proliferation involved in contact inhibition
|
GO:0060244 |
3 |
0.013
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.013
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.013
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.013
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.013
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.012
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.012
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.012
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.012
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.012
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.012
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.012
|
|
|
|
membrane raft assembly
|
GO:0001765 |
3 |
0.012
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.012
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.012
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.012
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.012
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.012
|
|
|
|
peptidyl proline hydroxylation
|
GO:0019511 |
3 |
0.012
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.012
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.012
|
|
|
|
fatty acid transport
|
GO:0015908 |
28 |
0.012
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.012
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.012
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.012
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.012
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.012
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.012
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.012
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.012
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.012
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.012
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.011
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.011
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.011
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.011
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.011
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.011
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.011
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.011
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.011
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.011
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.011
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.011
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.011
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.011
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.011
|
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.011
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.011
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.011
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.011
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.011
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.011
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.011
|
|
|
|
notochord development
|
GO:0030903 |
20 |
0.011
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.011
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.011
|
|
|
|
negative regulation of odontogenesis
|
GO:0042483 |
3 |
0.011
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.011
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.011
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.011
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.011
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.011
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.011
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.011
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.011
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.011
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.010
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.010
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.010
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.010
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.010
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.010
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.010
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.010
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.010
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.010
|
|
|
|
acetylcholine secretion neurotransmission
|
GO:0014055 |
2 |
0.010
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.010
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.010
|
|